Tariff Pause Offers Much-Needed Relief to Pharmaceutical Companies

Summary:Indian drug makers can breathe easier because the US reportedly shelves its plan for price lists…

Indian Pharma Alliance: Trump’s 100% Tariff Won’t Hurt Generic Medicine Makers

Summary: Trump’s proposed one hundred% tariff on imported pharmaceuticals will in general influence patented and branded…

Trump’s 25% Pharma Tariffs Indian Pharma Outliers and Strategic Paths Ahead

Summary:Trump has announced a 25% tariff on Indian drug exports to America along with unspecified punishment…

Siemens Healthineers Warns of €300 Million Tariff Hit Despite Revenue Growth

Siemens Healthineers (SHLG.DE) anticipates a tariff impact of up to 300 million euros (\$341 million) on…

GE Healthcare Lowers 2025 Earnings Outlook as Tariffs Bite, Despite Strong Q1 Performance

GE Healthcare has revised its 2025 adjusted earnings guidance downward, citing an expected 85-cent-per-share hit from…

Logo
Facebook
Twitter
Copyright @ 2025 Indiagnostic. All rights reserved.